Making cancer drugs less expensive

The price of cancer drugs is too high, an increasingly significant issue in U.S. health care expenditures. In this op-ed for the Washington Post, Hagop Kantarjian, scholar in health policy, explains how to reduce the price of cancer drugs.

Read the full Feb. 22, 2013, article here.